UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

Oncotarget, 2017-02, Vol.8 (9), p.16052-16074

2017

Volltextzugriff (PDF)

Histologic Transformation in EGFR-Mutant Lung Adenocarcinomas: Mechanisms and Therapeutic Implications

Cancers, 2021-09, Vol.13 (18), p.4641

2021

Volltextzugriff (PDF)

Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists

Journal of clinical oncology, 2013-03, Vol.31 (9), p.1134-1139

2013

Volltextzugriff (PDF)

Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?

Current treatment options in oncology, 2023-07, Vol.24 (7), p.845-866

2023

Volltextzugriff (PDF)

Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure

Cancers, 2020-12, Vol.12 (12), p.3851

2020

Volltextzugriff (PDF)

Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases

The oncologist (Dayton, Ohio), 2021-12, Vol.26 (12), p.1052-1061

2021

Volltextzugriff (PDF)

The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer

Frontiers in oncology, 2021-07, Vol.11, p.649963-649963

2021

Volltextzugriff (PDF)

Building Team Medicine in the Management of CNS Metastases

Journal of clinical medicine, 2023-06, Vol.12 (12), p.3901

2023

Volltextzugriff (PDF)

Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers

Cancer research (Chicago, Ill.), 2013, Vol.73 (1), p.184-194

2013

Volltextzugriff (PDF)

Multidisciplinary approach for patients with esophageal cancer

World journal of gastroenterology : WJG, 2012-12, Vol.18 (46), p.6737-6746

2012

Volltextzugriff (PDF)

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2735-2743

2014

Volltextzugriff (PDF)

Experts Examine Tipifarnib to Treat HNSCC With HRAS Mutations

Oncology (Williston Park, N.Y.), 2021-11, Vol.35 (11), p.770

2021

Volltextzugriff (PDF)

The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Clinical lung cancer, 2021-01, Vol.22 (1), p.e57-e62

2021

Volltextzugriff (PDF)

Reply to Letter to the Editor

Clinical lung cancer, 2022-05, Vol.23 (3), p.e173-e173

2022

Volltextzugriff (PDF)

Survivorship support in head and neck cancer: American Head and Neck Society survey

Head & neck, 2020-05, Vol.42 (5), p.939-944

2020

Volltextzugriff (PDF)

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials

Oncotarget, 2017-01, Vol.8 (5), p.8910-8920

2017

Volltextzugriff (PDF)

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Clinical cancer research, 2008-04, Vol.14 (7), p.2088-2094

2008

Volltextzugriff (PDF)

Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma

British journal of cancer, 2022-11, Vol.127 (8), p.1497-1506

2022

Volltextzugriff (PDF)

AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2015-06, Vol.21 (11), p.2601-2612

2015

Volltextzugriff (PDF)

Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?

Current treatment options in oncology, 2023-09, Vol.24 (9), p.1138-1166

2023

Volltextzugriff (PDF)

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

Head & neck oncology, 2011-07, Vol.3 (1), p.31-31, Article 31

2011

Volltextzugriff (PDF)

BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors

Cancer gene therapy, 2024-04, Vol.31 (4), p.517-526

2024

Volltextzugriff (PDF)

Neoadjuvant Treatment for Locally Invasive Esophageal Cancer

World journal of surgery, 2017-07, Vol.41 (7), p.1719-1725

2017

Volltextzugriff (PDF)

Nasopharyngeal Cancer: Is the Addition of Chemotherapy to Radiotherapy Worthwhile in an Era of Value-Based Care?

JCO oncology practice, 2020-11, Vol.16 (11), p.711-712

2020

Volltextzugriff (PDF)

Neoadjuvant treatment of esophageal cancer

World journal of gastroenterology : WJG, 2010-08, Vol.16 (30), p.3793-3803

2010

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(59)
Buchkapitel
(1)

Sprache

Englisch
(60)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(32)
Oncology
(32)
Aged
(14)
Female
(14)
Male
(14)
Immunotherapy
(12)
Chemotherapy
(10)
Middle Aged
(10)
Adult
(9)
Tumors
(9)
Chemoradiotherapy
(8)
Treatment Outcome
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Prognosis
(7)
Biological And Medical Sciences
(6)
Esophageal Cancer
(6)
Immune Checkpoint Inhibitors
(6)
Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(6)
Journal Of Thoracic Oncology
(6)
Oncotarget
(5)
Clinical Cancer Research
(4)
Cancer Research
(3)
Clinical Lung Cancer
(3)
Cancer
(2)
Cancers
(2)
Current Treatment Options In Oncology
(2)
Head & Neck
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

Histologic Transformation in EGFR-Mutant Lung Adenocarcinomas: Mechanisms and Therapeutic Implications

Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists

Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?

Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure

Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases

The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer

Building Team Medicine in the Management of CNS Metastases

Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers

Multidisciplinary approach for patients with esophageal cancer

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

Experts Examine Tipifarnib to Treat HNSCC With HRAS Mutations

The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Reply to Letter to the Editor

Survivorship support in head and neck cancer: American Head and Neck Society survey

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma

AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors

Neoadjuvant Treatment for Locally Invasive Esophageal Cancer

Nasopharyngeal Cancer: Is the Addition of Chemotherapy to Radiotherapy Worthwhile in an Era of Value-Based Care?

Neoadjuvant treatment of esophageal cancer

Suchergebnisse filtern